TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development13,34228,53335,504
Selling General and Administrative7,94910,43612,658
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-21,291-38,969-48,162
Income from Continuing Operations
Total Other Income/Expenses Net168127108
Earnings Before Interest and Taxes-21,123-38,842-48,054
Interest Expense---
Income Before Tax-21,123-38,842-48,054
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-21,123-38,842-48,054
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-21,123-38,842-48,054
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-21,123-38,842-48,054